R markdown

eval: how are you.

M1234 Analysis

Information

Study :12345
Indication: Cancer
Start date: 08^th Nov 2024_DSUR
AE Special interest information

Image loading

—-This is the image—

In line coding

Adverse events that occured to more than 5 subjects are ABDOMINAL DISCOMFORT, ACROCHORDON EXCISION, ACTINIC KERATOSIS, ALCOHOL USE, ALLERGIC GRANULOMATOUS ANGIITIS

Dataset

interactive

Click here 😊

static

STUDYID	USUBJID	SUBJID	RFSTDTC	RFENDTC	RFXSTDTC	RFXENDTC	RFICDTC	RFPENDTC	DTHDTC	DTHFL	SITEID	AGE	AGEU	SEX	RACE	ETHNIC	ARMCD	ARM	ACTARMCD	ACTARM	COUNTRY	DMDTC	DMDY	TRT01P	TRT01A	TRTSDTM	TRTSTMF	TRTEDTM	TRTETMF	TRTSDT	TRTEDT	TRTDURD	SCRFDT	EOSDT	EOSSTT	FRVDT	RANDDT	DTHDT	DTHDTF	DTHADY	LDDTHELD	DTHCAUS	DTHDOM	DTHCGR1	LSTALVDT	SAFFL	RACEGR1	AGEGR1	REGION1	LDDTHGR1	DTH30FL	DTHA30FL	DTHB30FL
CDISCPILOT01	01-701-1015	1015	2014-01-02	2014-07-02	2014-01-02	2014-07-02	NA	2014-07-02T11:45	NA	NA	701	63	YEARS	F	WHITE	HISPANIC OR LATINO	Pbo	Placebo	Pbo	Placebo	USA	2013-12-26	-7	Placebo	Placebo	2014-01-02	H	2014-07-02 23:59:59	H	2014-01-02	2014-07-02	182	NA	2014-07-02	COMPLETED	NA	2014-01-02	NA	NA	NA	NA	NA	NA	NA	2014-07-02	Y	White	18-64	NA	NA	NA	NA	NA
CDISCPILOT01	01-701-1023	1023	2012-08-05	2012-09-02	2012-08-05	2012-09-01	NA	2013-02-18	NA	NA	701	64	YEARS	M	WHITE	HISPANIC OR LATINO	Pbo	Placebo	Pbo	Placebo	USA	2012-07-22	-14	Placebo	Placebo	2012-08-05	H	2012-09-01 23:59:59	H	2012-08-05	2012-09-01	28	NA	2012-09-02	DISCONTINUED	2013-02-18	2012-08-05	NA	NA	NA	NA	NA	NA	NA	2012-09-02	Y	White	18-64	NA	NA	NA	NA	NA
CDISCPILOT01	01-701-1028	1028	2013-07-19	2014-01-14	2013-07-19	2014-01-14	NA	2014-01-14T11:10	NA	NA	701	71	YEARS	M	WHITE	NOT HISPANIC OR LATINO	Xan_Hi	Xanomeline High Dose	Xan_Hi	Xanomeline High Dose	USA	2013-07-11	-8	Xanomeline High Dose	Xanomeline High Dose	2013-07-19	H	2014-01-14 23:59:59	H	2013-07-19	2014-01-14	180	NA	2014-01-14	COMPLETED	NA	2013-07-19	NA	NA	NA	NA	NA	NA	NA	2014-01-14	Y	White	>64	NA	NA	NA	NA	NA
CDISCPILOT01	01-701-1033	1033	2014-03-18	2014-04-14	2014-03-18	2014-03-31	NA	2014-09-15	NA	NA	701	74	YEARS	M	WHITE	NOT HISPANIC OR LATINO	Xan_Lo	Xanomeline Low Dose	Xan_Lo	Xanomeline Low Dose	USA	2014-03-10	-8	Xanomeline Low Dose	Xanomeline Low Dose	2014-03-18	H	2014-03-31 23:59:59	H	2014-03-18	2014-03-31	14	NA	2014-04-14	DISCONTINUED	2014-09-15	2014-03-18	NA	NA	NA	NA	NA	NA	NA	2014-04-14	Y	White	>64	NA	NA	NA	NA	NA
CDISCPILOT01	01-701-1034	1034	2014-07-01	2014-12-30	2014-07-01	2014-12-30	NA	2014-12-30T09:50	NA	NA	701	77	YEARS	F	WHITE	NOT HISPANIC OR LATINO	Xan_Hi	Xanomeline High Dose	Xan_Hi	Xanomeline High Dose	USA	2014-06-24	-7	Xanomeline High Dose	Xanomeline High Dose	2014-07-01	H	2014-12-30 23:59:59	H	2014-07-01	2014-12-30	183	NA	2014-12-30	COMPLETED	NA	2014-07-01	NA	NA	NA	NA	NA	NA	NA	2014-12-30	Y	White	>64	NA	NA	NA	NA	NA
CDISCPILOT01	01-701-1047	1047	2013-02-12	2013-03-29	2013-02-12	2013-03-09	NA	2013-07-28	NA	NA	701	85	YEARS	F	WHITE	NOT HISPANIC OR LATINO	Pbo	Placebo	Pbo	Placebo	USA	2013-01-22	-21	Placebo	Placebo	2013-02-12	H	2013-03-09 23:59:59	H	2013-02-12	2013-03-09	26	NA	2013-03-29	DISCONTINUED	2013-07-28	2013-02-12	NA	NA	NA	NA	NA	NA	NA	2013-04-07	Y	White	>64	NA	NA	NA	NA	NA

Plots

loop

01-701-1015

Adverse events: APPLICATION SITE ERYTHEMA APPLICATION SITE PRURITUS DIARRHOEA

01-701-1023

Adverse events: ERYTHEMA ERYTHEMA ERYTHEMA ATRIOVENTRICULAR BLOCK SECOND DEGREE

01-701-1028

Adverse events: APPLICATION SITE ERYTHEMA APPLICATION SITE PRURITUS

01-701-1033

Adverse events:

01-701-1034

Adverse events: APPLICATION SITE PRURITUS FATIGUE